AbbVie Inc.
ABBV
$218.09
$3.591.67%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.64B | 4.23B | 2.39B | 3.76B | 4.20B |
| Total Depreciation and Amortization | 8.04B | 8.14B | 8.25B | 8.27B | 8.35B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.26B | 9.03B | 12.50B | 10.04B | 9.46B |
| Change in Net Operating Assets | -1.70B | -2.36B | -2.29B | -2.79B | -5.61B |
| Cash from Operations | 21.22B | 19.03B | 20.86B | 19.28B | 16.40B |
| Capital Expenditure | -1.24B | -1.21B | -1.18B | -1.04B | -1.02B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.17B | -5.44B | -6.07B | -11.76B | -11.67B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.00M | 12.00M | 194.00M | 761.00M | 715.00M |
| Cash from Investing | -6.48B | -6.64B | -7.05B | -12.05B | -11.97B |
| Total Debt Issued | 11.70B | 9.29B | 11.79B | 11.55B | 7.59B |
| Total Debt Repaid | -9.07B | -9.60B | -14.56B | -12.95B | -12.54B |
| Issuance of Common Stock | 116.00M | 116.00M | 78.00M | 82.00M | 87.00M |
| Repurchase of Common Stock | -1.51B | -980.00M | -1.34B | -1.35B | -1.35B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.82B | -11.66B | -11.50B | -11.34B | -11.18B |
| Other Financing Activities | 36.00M | 101.00M | 103.00M | 98.00M | 100.00M |
| Cash from Financing | -10.55B | -12.72B | -15.42B | -13.90B | -17.29B |
| Foreign Exchange rate Adjustments | 21.00M | 42.00M | -15.00M | 1.00M | -38.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.22B | -295.00M | -1.63B | -6.66B | -12.89B |